The role of FOXP3

Anemia, Pernicious / immunology Animals Autoimmune Diseases / genetics Autoimmunity CTLA-4 Antigen / deficiency Cell- and Tissue-Based Therapy / methods Diabetes Mellitus, Type 1 / congenital Diarrhea / genetics Forkhead Transcription Factors / genetics Genetic Diseases, X-Linked / genetics Humans Immune System Diseases / congenital Immunotherapy / methods Inflammation / immunology Interleukin-2 / immunology Mice Models, Immunological T-Lymphocytes, Regulatory / classification
T regulatory cells Treg autoimmune cell therapy inflammation

Journal

Clinical and experimental immunology
ISSN: 1365-2249
Titre abrégé: Clin Exp Immunol
Pays: England
ID NLM: 0057202

Informations de publication

Date de publication:
07 2019
Historique:
accepted: 21 01 2019
pubmed: 5 3 2019
medline: 9 4 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

CD4

Identifiants

DOI: 10.1111/cei.13288 PMID: 30830965 PMC: PMC6591146
pubmed: 30830965
doi: 10.1111/cei.13288
pmc: PMC6591146
doi:

Substances chimiques

CTLA-4 Antigen 0
CTLA4 protein, human 0
FOXP3 protein, human 0
Forkhead Transcription Factors 0
IL2 protein, human 0
Interleukin-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-35

Informations de copyright

© 2019 British Society for Immunology.

Références

Nat Genet. 2001 Jan;27(1):18-20
pubmed: 11137992
Nat Genet. 2001 Jan;27(1):20-1
pubmed: 11137993
Nat Genet. 2001 Jan;27(1):68-73
pubmed: 11138001
Eur J Immunol. 2001 Apr;31(4):1122-31
pubmed: 11298337
Eur J Immunol. 2001 Apr;31(4):1247-54
pubmed: 11298351
J Exp Med. 2001 Jun 4;193(11):1285-94
pubmed: 11390435
J Exp Med. 2001 Jun 4;193(11):1295-302
pubmed: 11390436
J Exp Med. 2001 Jun 4;193(11):1303-10
pubmed: 11390437
J Immunol. 2001 Aug 1;167(3):1245-53
pubmed: 11466340
Blood. 2001 Nov 1;98(9):2736-44
pubmed: 11675346
J Immunol. 2002 Dec 1;169(11):6210-7
pubmed: 12444126
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
Nat Immunol. 2003 Apr;4(4):330-6
pubmed: 12612578
Nat Immunol. 2003 Apr;4(4):337-42
pubmed: 12612581
J Clin Endocrinol Metab. 2003 Jul;88(7):2983-92
pubmed: 12843130
J Clin Invest. 2003 Nov;112(9):1437-43
pubmed: 14597769
J Immunol. 2003 Nov 15;171(10):5012-7
pubmed: 14607897
J Exp Med. 2004 Apr 5;199(7):971-9
pubmed: 15067033
Clin Exp Immunol. 2004 Jun;136(3):463-71
pubmed: 15147348
Hum Immunol. 2005 Jan;66(1):13-20
pubmed: 15620457
J Exp Med. 2006 Feb 20;203(2):359-70
pubmed: 16432251
Science. 2006 Mar 31;311(5769):1924-7
pubmed: 16484453
Blood. 2006 Nov 15;108(10):3371-8
pubmed: 16868256
Blood. 2006 Dec 15;108(13):4260-7
pubmed: 16917003
Nat Immunol. 2007 Feb;8(2):191-7
pubmed: 17136045
Trends Mol Med. 2007 Mar;13(3):108-16
pubmed: 17257897
Clin Exp Immunol. 2007 Apr;148(1):32-46
pubmed: 17328715
N Engl J Med. 2007 Aug 30;357(9):851-62
pubmed: 17660530
Nat Immunol. 2007 Dec;8(12):1353-62
pubmed: 17982458
Eur J Immunol. 2008 Jun;38(6):1654-63
pubmed: 18493985
Cell. 2008 May 30;133(5):775-87
pubmed: 18510923
Immunity. 2008 Jul 18;29(1):44-56
pubmed: 18585065
Blood. 2008 Sep 15;112(6):2340-52
pubmed: 18617638
Science. 2008 Oct 10;322(5899):271-5
pubmed: 18845758
Blood. 2009 Apr 30;113(18):4240-9
pubmed: 19171879
Nature. 2009 Mar 19;458(7236):351-6
pubmed: 19182775
Eur J Immunol. 2009 Apr;39(4):1088-97
pubmed: 19283780
J Allergy Clin Immunol. 2009 Apr;123(4):749-55; quiz 756-7
pubmed: 19348913
Immunity. 2009 Jun 19;30(6):899-911
pubmed: 19464196
Immunity. 2009 May;30(5):636-45
pubmed: 19464986
Clin Immunol. 2009 Oct;133(1):22-6
pubmed: 19559653
Science. 2009 Nov 13;326(5955):986-91
pubmed: 19797626
J Immunol. 2009 Dec 15;183(12):7631-4
pubmed: 19923467
Eur J Immunol. 2010 May;40(5):1232-40
pubmed: 20148422
Eur J Immunol. 2010 Jun;40(6):1538-40
pubmed: 20458706
Int J Cancer. 2010 Aug 15;127(4):759-67
pubmed: 20518016
Nat Rev Immunol. 2010 Jul;10(7):490-500
pubmed: 20559327
Blood. 2011 Jan 20;117(3):1061-70
pubmed: 20952687
Blood. 2011 Apr 7;117(14):3921-8
pubmed: 21292771
Immunol Cell Biol. 2011 Mar;89(3):346-51
pubmed: 21301480
Autoimmun Rev. 2011 Oct;10(12):744-55
pubmed: 21621000
J Immunol. 2011 Sep 1;187(5):2061-6
pubmed: 21856944
Maedica (Buchar). 2010 Dec;5(4):286-91
pubmed: 21977172
N Engl J Med. 2011 Dec 1;365(22):2067-77
pubmed: 22129253
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Blood. 2012 May 10;119(19):4430-40
pubmed: 22438251
Diabetes. 2012 Sep;61(9):2340-8
pubmed: 22721971
Immunity. 2012 Nov 16;37(5):785-99
pubmed: 23123060
Nat Med. 2014 Jan;20(1):62-8
pubmed: 24362934
Immunol Rev. 2014 May;259(1):88-102
pubmed: 24712461
Arthritis Rheumatol. 2014 Sep;66(9):2344-54
pubmed: 24891289
Nat Rev Rheumatol. 2014 Sep;10(9):543-51
pubmed: 24980140
Immunol Lett. 2014 Nov;162(1 Pt A):41-8
pubmed: 24996040
PLoS One. 2014 Aug 13;9(8):e104698
pubmed: 25119105
Science. 2014 Sep 26;345(6204):1623-1627
pubmed: 25213377
Blood. 2014 Dec 4;124(24):3572-6
pubmed: 25323825
Nat Med. 2014 Dec;20(12):1410-1416
pubmed: 25329329
Autoimmun Rev. 2015 Feb;14(2):105-16
pubmed: 25449680
IUBMB Life. 2015 Feb;67(2):88-97
pubmed: 25850692
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7225-30
pubmed: 26015572
Inflamm Bowel Dis. 2015 Aug;21(8):1982-92
pubmed: 26154136
Science. 2015 Jul 24;349(6246):436-40
pubmed: 26206937
Trends Immunol. 2015 Dec;36(12):763-777
pubmed: 26572555
Sci Transl Med. 2015 Nov 25;7(315):315ra189
pubmed: 26606968
J Clin Immunol. 2016 Jan;36(1):33-45
pubmed: 26707784
Immunol Rev. 2016 May;271(1):246-59
pubmed: 27088919
Nat Med. 2016 Jun;22(6):679-84
pubmed: 27111280
Clin Exp Immunol. 2016 Sep;185(3):281-91
pubmed: 27124481
Annu Rev Immunol. 2016 May 20;34:609-33
pubmed: 27168246
Front Immunol. 2016 May 18;7:193
pubmed: 27242798
Nat Immunol. 2016 Nov;17(11):1322-1333
pubmed: 27595233
Curr Rheumatol Rep. 2016 Nov;18(11):68
pubmed: 27734211
Immunity. 2016 Nov 15;45(5):1122-1134
pubmed: 27851913
Immunity. 2016 Nov 15;45(5):1135-1147
pubmed: 27851914
Nature. 2017 Jun 15;546(7658):421-425
pubmed: 28607488
J Clin Invest. 2017 Jun 30;127(7):2505-2512
pubmed: 28665300
Front Immunol. 2017 Jun 28;8:748
pubmed: 28702031
JCI Insight. 2017 Aug 17;2(16):null
pubmed: 28814673
J Immunol. 2018 Jan 1;200(1):336-346
pubmed: 29180490
Oncotarget. 2016 Jul 28;8(62):104733-104744
pubmed: 29285209
Clin Transl Immunology. 2018 Jan 30;7(1):e1005
pubmed: 29484183
Sci Rep. 2018 May 9;8(1):7428
pubmed: 29743501
Immunity. 2018 May 15;48(5):1046-1059.e6
pubmed: 29752063
Front Immunol. 2018 May 15;9:1048
pubmed: 29868011
Nat Immunol. 2018 Jul;19(7):665-673
pubmed: 29925983
J Immunol. 2018 Nov 1;201(9):2579-2592
pubmed: 30282751
J Cell Physiol. 2019 Jun;234(6):7983-7993
pubmed: 30317612
Immunol Rev. 2019 Jan;287(1):33-49
pubmed: 30565239
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184
N Engl J Med. 1997 Nov 13;337(20):1441-8
pubmed: 9358143

Auteurs

A Mohr (A)

Sorbonne Université, Inserm, Centre d'immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France.

M Atif (M)

Sorbonne Université, Inserm, Centre d'immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France.

R Balderas (R)

BD Biosciences, San Diego, CA, USA.

G Gorochov (G)

Sorbonne Université, Inserm, Centre d'immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France.
Sorbonne Université, Inserm, Centre d'immunologie et des maladies infectieuses, Paris, France (Cimi-Paris), AP-HP Hôpital Pitié-Salpêtrière, Paris, France.

M Miyara (M)

Sorbonne Université, Inserm, Centre d'immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France.
Sorbonne Université, Inserm, Centre d'immunologie et des maladies infectieuses, Paris, France (Cimi-Paris), AP-HP Hôpital Pitié-Salpêtrière, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Troubles nutritionnels › Malnutrition › Maladies de carence › Avitaminoses › Carence en vitamines B › Carence en vitamine B12 › Anémie pernicieuse › The role of FOXP3
questionsmedicales.fr › Eucaryotes › Animaux › The role of FOXP3
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › The role of FOXP3
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Auto-immunité › The role of FOXP3
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes de différenciation des lymphocytes T › Antigène CTLA-4 › The role of FOXP3
questionsmedicales.fr › Thérapeutique › Biothérapie › Thérapie cellulaire et tissulaire › The role of FOXP3
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Diabète de type 1 › The role of FOXP3
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes digestifs › Diarrhée › The role of FOXP3
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription à motif hélice ailée › Facteurs de transcription Forkhead › The role of FOXP3
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Maladies génétiques liées au chromosome X › The role of FOXP3
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The role of FOXP3
questionsmedicales.fr › Maladies du système immunitaire › The role of FOXP3
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › The role of FOXP3
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › The role of FOXP3
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Lymphokines › Interleukine-2 › The role of FOXP3
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › The role of FOXP3
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles immunologiques › The role of FOXP3
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T régulateurs › The role of FOXP3